Patents by Inventor Rachael Lansdown

Rachael Lansdown has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Integrase inhibitors
    Patent number: 8008287
    Abstract: Tricyclic compounds, protected intermediates thereof, and methods for inhibition of HIV-integrase are disclosed.
    Type: Grant
    Filed: May 16, 2007
    Date of Patent: August 30, 2011
    Assignee: Gilead Sciences, Inc.
    Inventors: Zhenhong R. Cai, Salman Y. Jabri, Haolun Jin, Rachael A. Lansdown, Samuel E. Metobo, Michael R. Mish, Richard M. Pastor
  • Integrase inhibitors
    Publication number: 20080058315
    Abstract: Tricyclic compounds, protected intermediates thereof, and methods for inhibition of HIV-integrase are disclosed.
    Type: Application
    Filed: May 16, 2007
    Publication date: March 6, 2008
    Inventors: Zhenhong Cai, Salman Jabri, Haolun Jin, Rachael Lansdown, Samuel Metobo, Michael Mish, Richard Pastor
  • Integrase inhibitor compounds
    Publication number: 20070072831
    Abstract: Tricyclic compounds, protected intermediates thereof, and methods for inhibition of HIV-integrase are disclosed.
    Type: Application
    Filed: May 16, 2006
    Publication date: March 29, 2007
    Inventors: Zhenhong Cai, Salman Jabri, Haolun Jin, Choung Kim, Rachael Lansdown, Samuel Metobo, Michael Mish, Richard Pastor